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The impact of atrial dispersion of refractoriness (Disp_A) in the inducibility and maintenance of atrial fibrillation (AF) has not been fully
resolved. Aim: To study the Disp_A and the vulnerability (A_Vuln) for the induction of self-limited (b60 s) and sustained episodes of AF.
Methods and results: Forty-seven patients with paroxysmal AF (PAF): 29 patients without structural heart disease and 18 with hypertensive
heart disease. Atrial effective refractory period (ERP) was assessed at five sites - right atrial appendage and low lateral right atrium, high
interatrial septum, proximal and distal coronary sinus. We compared three groups: group A - AF not inducible (n=13); group B - AF
inducible, self-limited (n=18); group C - AF inducible, sustained (n=16). Age, lone AF, hypertension, left atrial and left ventricular (LV)
dimensions, LV systolic function, duration of AF history, atrial flutter/tachycardia, previous antiarrhythmics, and Disp_Awere analysed with
logistic regression to determine association with A_Vuln for AF inducibility. The ERP at different sites showed no differences among the
groups. Group A had a lower Disp_A compared to group B (47±20 ms vs 82±65 ms; p=0.002), and when compared to group C (47±20 ms
vs 80±55 ms; p=0.008). There was no significant difference in Disp_A between groups B and C. By means of multivariate regression
analysis, the only predictor of A_Vuln was Disp_A (p=0.04). Conclusion: In patients with PAF, increased Disp_A represents an
electrophysiological marker of A_Vuln. Inducibility of both self-limited and sustained episodes of AF is associated with similar values of
Disp_A. These findings suggest that the maintenance of AF is influenced by additional factors.
© 2008 Elsevier Ireland Ltd. All rights reserved.Keywords: Dispersion of refractoriness; Atrial vulnerability; Non-sustained and sustained atrial fibrillation1. Introduction
Atrial fibrillation (AF) is the most common sustained
cardiac arrhythmia in the general practice setting. Its
prevalence increases with age, from 0.4% in the general
population to more than 5% over the age of 65 [1,2], and it is
recognized as a potentially dangerous arrhythmia, with
impact on both life expectancy and quality of life [3,4]. AF
remains a considerable clinical challenge, in part due to our⁎ Corresponding author.
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doi:10.1016/j.ijcard.2008.04.097limitations in understanding the electrophysiological
mechanisms underlying the condition. Despite the amount
of recent information on management and therapeutic
strategies on AF, we still have limited knowledge regarding
the mechanisms of arrhythmia recurrence and progression to
sustained AF. In fact, paroxysmal AF, defined as recurrent,
self-terminating within 7 days of onset, progresses to
persistent AF in over 18% of patients, even if there is no
sign of underlying structural heart disease [5,6].
Electrical remodelling of the atrial tissue, which is
associated with shortening of the atrial refractory period in
a heterogeneous way, is known to be related with atrial
vulnerability for the occurrence of spontaneous and inducible
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arrhythmia [7]. Patients with inducible AF are at an increased
risk of AF recurrence, even after pulmonary vein isolation
[8,9]. Atrial effective refractory periods (ERP) and its spatial
dispersion heterogeneity have been accepted to promote AF
re-initiation and to provide a substrate for the re-entry of
multiple wavelets to enhance the ability of the disorder to
sustaining itself [10,11]. Also, an increase in the electrical
homogeneity or a decrease in the dispersion of refractoriness
may contribute to decrease the number of wavelets and lead
to the AF termination [12]. Studies have shown that spatial
dispersion of refractoriness is involved in the maintenance
of AF [13,14]. Increased dispersion of atrial refractoriness
and shortening of wavelength have been also correlated
with initiation and maintenance of AF after its induction
in a pacing-induced model of AF in the pig [15].
Nevertheless, there is lack of data concerning the impact of
the degree of the non-uniformity of ERP on the vulnerability
for the inducibility and for the persistence of AF among
humans.
In the present study, we investigated whether the
dispersion of atrial refractoriness influences the vulnerability
for the induction of AF in patients with paroxysmal AF
(PAF). Additionally, we evaluated the relationship between
the magnitude of atrial refractoriness dispersion and
inducibility of self-limited and self-sustained AF.
2. Methods
2.1. Patient population
The study consisted of 47 patients referred to our
institution, with ≥1 year duration of clinical history of
PAF, despite antiarrhythmic therapy. PAF was documented
with electrocardiograms and/or Holter recordings. Patients
with evidence of sick sinus syndrome, failure to remain in
stable sinus rhythm while in-hospital monitoring before the
electrophysiological study (EPS), permanent pacemaker
implanted, bronchopulmonary disease and pregnancy or
thyroid dysfunction were not included in the study. Prior
to the EPS, all antiarrhythmic drugs were withdrawn for at
least 5 half-life times. Patients under amiodarone stopped
treatment 2 months before the EPS. The study protocol was
approved by the local ethics. All subjects were required to
give written informed consent.
The study protocol was performed according to the
ethical guidelines of the Declaration of Helsinki.
2.2. Electrophysiological protocol
All patients underwent EPS in a non-sedated postabsorp-
tive state. No serum electrolyte disturbances were found.
Electrical programmed stimulation and recording of
electrograms were performed by using 6F catheter electrodes
inserted percutaneously into the femoral and internal jugular
veins. A quadripolar electrode catheter (2-mm-spaced; DaigCo) was positioned in the right atrial appendage (RAA), and
moved to the low right posterolateral atrium (LRA) and high
interatrial septum (IAS), a second quadripolar electrode
catheter (2-mm-spaced; Daig Co) was inserted into the His
bundle area (HBE), and a 2-mm-spaced decapolar electrode
catheter (Daig Co) was advanced into the coronary sinus
(CS). All bipolar electrograms were recorded using a multi-
channel electrophysiological recorder (Bard Lab System)
with a frequency response of 50–500 Hz onto optical disks
for later analysis. Twelve-lead surface ECGs were also
simultaneously recorded. Hard copies of the electrograms
were printed at a recording speed of 100 mm/s.
As a measure of local refractoriness, ERP were assessed
in each patient at five different sites (RAA, LRA, IAS,
proximal and distal CS). Under stable conditions, a
programmed electrical stimulation using a single premature
stimulus (S2) was delivered, while pacing continuously at a
basic drive cycle length of 600 ms. Stimulation was
performed with impulses of 2 ms duration at twice the
diastolic threshold. A premature beat was introduced in late
diastole, beginning at a coupling interval of 100 ms less than
the basic cycle length. The coupling interval of the premature
stimulation was decreased by 10 ms steps until the ERP was
reached. The ERP were taken as the longest S1–S2 intervals
that failed to initiate a propagation response. Dispersion of
refractoriness was obtained in all patients as the difference
between the longest and the shortest ERP at the five
stimulation sites.
All patients underwent programmed bipolar stimulation
(drive-train cycle length of 600 ms using S2–S3 extra-
stimuli) and incremental pacing protocols (short-term of
burst pacing range from 600 to 300 ms) during sinus rhythm
by pacing from the distal electrode pairs positioned at the
RAA and distal CS catheters. AF was defined as a rapid atrial
rhythm (rate N350 beats/min) characterized by variability of
the beat-to-beat cycle length, polarity, configuration and
amplitude of the recorded atrial electrograms and lasting
more than 5 cycles [16]. The concept of atrial vulnerability
was based on the ability to induce AF with 1–2 extra-stimuli
or with incremental atrial pacing during electrical stimulation
from the RAA or distal CS. If AF was induced, an external
electrical cardioversion was performed after ≥5 min of
continuous AF without spontaneous termination. In patients
requiring external cardioversion, a maximum of 3 shocks
was delivered. The patients were separated into group A —
AF not inducible, group B — AF inducible, self-limited
(b60 s), and group C — AF inducible, self-sustained,
terminated by therapeutic intervention.
2.3. Statistical analysis
The results are presented as mean value± standard
deviation. Categorical variables are expressed as frequencies
and percentages. Student's t test and repeated ANOVAwere
utilised for the analysis of continuous variables (overall
comparison). The Chi-square test was used to evaluate the
Table 1
Clinical characteristics of the patients.
Characteristic All patients Group A Group B Group C
(n=47) (n=13) (n=18) (n=16)
Age, years 56±14 57±13 54±15 57±14
Male gender 47% 47% 50% 44%
History of hypertension 36% 38.5% 33.3% 44%
Number of previous AA 1.7±0.8 1.6±0.9 1.4±0.8 2.0±0.5
LA≥22 mm/m2 36% 38.5% 38.9% 31%
LV hypertrophy 12.7% 15.3% 11.1% 12.5%
LVEFb50% 11.1% 15.4% 11.1% 6.3%
Duration of AF (years) 2.3±1.9 2.0±1.5 1.9±2.0 3.0±2.2
AFL/AT 11.1% 15.4% 5.6% 12.5%
AA=antiarrhythmics; LA=left atrium (M-mode measurements); LV=left
ventricle; LVEF=left ventricular ejection fraction; AF=atrial fibrillation;
AFL=atrial flutter; AT=atrial tachycardia.
None of the variables differed significantly between the groups.
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analysis was used to assess the relation of variables with
atrial vulnerability for the induction of AF. We tested the
following variables for all patients: age, sex, diagnosis of
lone PAF, history of systemic hypertension, left atrial
dimension, left ventricular ejection fraction, presence or
absence of left ventricular hypertrophy, duration of clinical
paroxysmal AF, number of previous antiarrhythmics,
documentation of atrial flutter, and dispersion of atrial
ERP. For all tests a value of pb0.05 was considered
statistically significant. Data were analyzed using GraphPAD
Instruments (GraphPad Software, Inc., California, USA).
3. Results
3.1. Patient characteristics
Forty-seven patients (47% male) with a mean age of 56±
14 years (range, 18 to 76 years) were subjected to this study.
The average duration of the history of PAF was 2.3±1.9 years
(median 1 year; range, 1 to 8 years).The population included
29 patients without structural heart disease and 18 with
hypertensive heart disease. AF was inducible in 72% of the
patients and non-inducible in 28%. The patients with atrial
vulnerability for arrhythmia induction showed self-limited AF
in 53% and self-sustained AF requiring electric intervention inTable 2
Effective refractory periods (ERP) measured at five atrial sites.
ERP (ms) Group A (n=13) Group B (n=18) Group C (n=16)
RAA 216±24 204±9 215±22
LRA (lateral) 218±24 217±24 210±14
IAS (high) 232±40 235±40 220±15
pCS 245±33⁎ 270±24⁎ 260±40⁎
dCS 242±34⁎ 340±126⁎ 256±35⁎
Data are expressed as mean±SD. RAA=right atrial appendage; LRA=low
right atrium; IAS= interatrial septum; pCS=proximal coronary sinus;
dCS=distal coronary sinus. pN0.05 for comparisons between the groups.
⁎ pb0.01 for comparisons between ERP in the pCS and dCS vs RAA and
LRA.47%. Group A included 13 patients (8 men and 5 women with
a mean age of 57±13 years). These patients had a 2.0±
1.5 years of clinical history of PAF, refractory to 1.6±0.9
antiarrhythmic drugs. Group B consisted of 18 patients (11
men and 7 women with a mean age of 54±15 years), who had
1.4±0.8 years of PAF, refractory to 1.9±2.0 antiarrhythmic
drugs. Group C was composed of 16 patients (10 men and 6
women with a mean age of 57±14 years), who had 2.0±
0.5 years of history of paroxysmal AF episodes, refractory to
3.0±2.2 antiarrhythmic drugs. There were no significant
differences regarding clinical and echocardiographic data
among the three groups (Table 1).Fig. 1. The line graphs summarize the dispersion of effective atrial refractory
periods for all the groups. Data are expressed asmean±SD. The lines represent
the mean, minimum and maximum values for each group. A. AF_vuln=pa-
tients with vulnerability for AF induction (n=34); no AF_vuln=patients
without AF induction (n=13). B. group A=AF not inducible (n=13); group
B=AF inducible, self-limited (b60 s) (n=18); group C=AF inducible, self-
sustained (n=16). Asterisks represent statistical significance (AF_vuln vs no
AF_vuln, p=0.01; group A vs group B, p=0.002; group A vs group C,
p=0.008).
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ERP values measured at the CS (proximal and distal)
were significantly higher when compared with the other
evaluated sites (Table 2). The mean ERP increased
progressively from the RAA, LRA, and IAS to the proximal
and distal CS (212±18 ms, 213±20 ms, 228±31 ms, 256±
33 ms and 273±73 ms respectively; ERP at the RAA vs
distal CS, pb0.01). There were no significant differences
among the ERP values measured in the three groups of
patients at any of the five sites that were assessed (Table 2).
However, dispersion of ERP was significantly higher in the
group of 34 patients who had atrial vulnerability for the
induction of AF compared with those who remained in sinus
rhythm during the EPS (80±60 ms vs 47±20 ms; p=0.01)
(Fig. 1). Moreover, the group A had a significant lower
dispersion of the mean ERP compared to the group B (47±
20 ms vs 82±65 ms; p=0.002) and when compared to the
group C (47±20 ms vs 80±55 ms; p=0.008). There was no
significant difference in dispersion of ERP between the
patients with AF lasting≤60 s and those with self-sustained
AF (Fig. 1). By means of multivariate logistic regression, the
only predictor of atrial vulnerability for the induction of AF
was dispersion of atrial ERP (p=0·04).
4. Discussion
4.1. Major findings
This study was designed to evaluate the impact of the
degree of dispersion of atrial ERP on the vulnerability for the
induction and maintenance of AF. The results have
demonstrated that ERP dispersion values are determinants
of atrial vulnerability. Increased dispersion of refractoriness
facilitated AF induction, but the ability to sustain AF may be
influenced by other factors in addition to the degree of the
non-uniformity of local ERP. In fact, despite a greater
dispersion of refractoriness in both groups with inducible
AF, the ERP dispersion was similar in patients with
inducibility of self-limited AF and in those patients who
have induction of AF lasting≥5 min. This suggests that the
electrophysiological substrate that creates the conditions for
the maintenance of AF is more complex, probably resulting
from the combination of different underlying mechanisms in
addition to the magnitude of atrial refractoriness dispersion.
It is more likely that multiple variables, including the effects
of autonomic nervous system, catecholamines, presence of
stretched segments of the atria, ischemia and electrolyte
imbalance, conduction abnormalities and other electrophy-
siological characteristics, contribute to the maintenance of
AF.
4.2. Atrial refractory periods
Shortening of the atrial ERP has been reported as one of
the main underlying electrophysiological changes in patientswith sustained AF [17]. Nevertheless, in our study the ERP
measurements at different sites where not different between
groups. Previous studies have demonstrated that AF lead to a
decrease in atrial ERP, without a significant change in
conduction velocity [18,19]. A shorter ERP can create a
shorter wavelength (ERP×conduction velocity), which
significantly contributes to the maintenance of AF [20]. In
our study, the ERP was gradually prolonged from the right to
the left side, with higher determinations in the proximal CS
and distal CS when compared with the RAA, LRA and IAS.
Those patients with induction of AF showed a larger
dispersion of refractoriness due to a marked difference
between ERP at the right atrium and those obtained along the
CS. These findings are in accordance with other authors,
who reported shorter ERP in the high right atrium when
compared with distal CS in patients with AF [7,21]. This
may be explained by a non-uniform distribution of vagal
nerve endings, which seems to cause greater changes in
refractory period in the RAA than in left atrium [22].
It is widely accepted that heterogeneity of electrophysio-
logical properties may play a major role in favouring re-entry
waves, and hence the initiation of AF [13,23]. Experimental
studies also suggested that ERP dispersion is an important
factor in determining the ability to sustain AF [24,25]. Our
results showed that dispersion of refractoriness is a suitable
indicator of atrial vulnerability for the induction of AF.
However, dispersion of atrial refractoriness was not
significantly increased in patients with self-sustained AF
when compared with the group with inducible non-sustained
AF.
4.3. Self-limited vs self-sustained atrial fibrillation
AF is generally considered to be maintained by multiple
re-entrant wavelets of excitation that propagate in different
directions around the atrial myocardium [26,27]. The
maintenance of AF seems to depend on the presence of a
sufficient number of small wavefronts while undergoing
fractionation, collisions and coalescence over the atrial
surface. To allow multiple re-entrant wavelets to propagate
resulting in a self-perpetuating activity, a critical mass of
excitable atrial tissue must exist [28]. Re-entry within the
atria is associated with shortening of the ERP with increased
dispersion of refractoriness, thereby providing a substrate for
initiation of AF. The concept of dispersion of refractoriness
is based on the non-uniformity of local atrial refractory
periods. This results in the coexistence of regions of the atria
with relatively short ERP in close proximity to areas with
much longer ERP, instead of a gradual transition. Also, re-
entrant wavelets must never encounter refractory tissue left
over by a previous wavelet, otherwise the wavelets will be
extinguished and the arrhythmia will not be sustained. Thus,
non-uniform changes in refractoriness are associated with an
increased frequency of induction of AF. However, when the
dispersion of refractoriness is too large, re-entrant wavelets
may be extinguished due to a slower recovery of adjacent
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wavelet arrives, the critical number of existing wavelets,
essential for the AF maintenance, will not be achieved.
Moreover, a larger number of circulating wavelets can exist
on the surface of larger atria. So, to accommodate the
maximum number of wavelets in a constant area, several
factors including atrial size, velocity of conduction and
dispersion of atrial refractory periods need to be adequately
combined.
Recently, in human studies, the presence of shorter ERP in
the pulmonary veins, when compared to left atrial refractori-
ness, was considered to provide a favourable milieu for the
initiation of AF and possibly to sustain fibrillatory activity
[29,30]. In addition, experimental evidence suggests that
certain cases of AF are maintained by small re-entrant
dominant frequency sources (rotors) [31,32]. Despite differ-
ent concepts to explain the perpetuation of AF, dispersion of
atrial refractoriness has been consistently associated with
vulnerability to the initiation and maintenance of AF.
4.4. Study limitations
First, the lack of a control group without history of AF
makes the comparison of the dispersion of ERP between our
patients and a population without the arrhythmia impossible.
However, the aim of this study was to assess the relationship
between the intensity of atrial refractoriness dispersion and
the vulnerability for the induction of self-limited and self-
sustained AF in a population with PAF. Second, the protocol
did not include measurements of the ERP from the
pulmonary veins and different left atrial sites. Therefore, it
is not possible to compare ERP to the right atrium and
pulmonary veins in this population. Nevertheless, in
previous studies, the distal CS ERP was accepted as
reflecting the ERP of the local left atrial tissue [21,33].
Finally, although the number of subjects included in the
study allowed for the identification of significant differences
in the dispersion of atrial refractoriness, the resulting sample
was relatively small, representing only a subpopulation of
patients with PAF and absent or minimal structural heart
disease. Thus, further studies in a larger group may be
needed to confirm these findings.
5. Conclusions
Increased atrial ERP dispersion enhances the propensity
for the inducibility of AF during electrophysiologic evalua-
tion. Nevertheless, patients with vulnerability for the
induction of AF lasting less than 1 min and those with
inducibility of self-sustained AF had similar and significant
increases in atrial dispersion of refractoriness. These results
emphasize the importance of the dispersion of ERP as an
electrophysiological marker of vulnerability for the induc-
tion of AF, and suggest that the maintenance of AF induced
during EPS is influenced by additional factors beyond the
degree of the non-uniformity of ERP.References
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